Evidence map›Paper›PMID 34644094›Full record

ArticleNano letters2021

Spectral- and Polarization-Dependent Scattering of Gold Nanobipyramids for Exogenous Contrast in Optical Coherence Tomography.

Pelham Keahey, Peng Si, Mohammad Razavi, Shangjie Yu, Norman Lippok, Martin Villiger, Timothy P Padera, Adam de la Zerda, Brett Bouma

Open access · hybridAbstract read
In one paragraph

Article in Nano letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Optical coherence tomography.Nature reviews. Methods primers · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Pelham KeaheyWellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.ORCID 0000-0002-9504-9696
Peng SiDepartment of Structural Biology, Stanford University, Stanford, California 94305, United States.ORCID 0000-0003-2596-8360
Mohammad RazaviHarvard Medical School, Boston, Massachusetts 02115, United States.
Shangjie YuDepartment of Electrical Engineering, Stanford University, Stanford, California 94305, United States.ORCID 0000-0002-5507-8425
Norman LippokWellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.
Martin VilligerWellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.
Timothy P PaderaHarvard Medical School, Boston, Massachusetts 02115, United States.
Adam de la ZerdaDepartment of Structural Biology, Stanford University, Stanford, California 94305, United States.
Brett BoumaWellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.
Harvard University · USChan Zuckerberg Initiative (United States) · USStanford Medicine · USStanford University · US

Funding

TRD3: Percutaneous and Interstitial ImagingP41EB015903 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI Jacqueline Namati · 2012 to 2026
$22.4M
Targeting lymph node metastases to prevent cancer progressionR01CA214913 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI PADERA, TIMOTHY P · 2017 to 2022
$2.0M
Molecular Imaging of Protein Glycosylation in Living SubjectsDP5OD012179 · OD · STANFORD UNIVERSITY · PI DE LA ZERDA, ADAM · 2012 to 2016
$2.0M
Point-of-care optical imaging to provide real-time histology to enable screening for cervical cancer and its precursorsK00CA212217 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI KEAHEY, PELHAM · 2018 to 2021
$383k
Regeneration and remodeling of collecting lymphatic vessels post-injuryF32HL156654 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI RAZAVI RIZI, MOHAMMAD · 2021 to 2024
$212k
Point-of-care optical imaging to provide real-time histology to enable screening for cervical cancer and its precursorsF99CA212217 · NCI · RICE UNIVERSITY · PI KEAHEY, PELHAM · 2016 to 2017
$89k
NCI NIH HHS F99 CA212217NCI NIH HHS K00 CA212217NCI NIH HHS R01 CA214913NHLBI NIH HHS F32 HL156654NIBIB NIH HHS P41 EB015903NIH HHS DP5 OD012179
6 · The paper itself

Abstract

Polarization-sensitive optical coherence tomography (PS-OCT) reveals the subsurface microstructure of biological tissue and provides information regarding the polarization state of light backscattered from tissue. Complementing OCT's structural signal with molecular imaging requires strategies to simultaneously detect multiple exogenous contrast agents with high specificity in tissue. Specific detection of molecular probes enables the parallel visualization of physiological, cellular, and molecular processes. Here we demonstrate that, by combining PS-OCT and spectral contrast (SC)-OCT measurements, we can distinguish signatures of different gold nanobipyramids (GNBPs) in lymphatic vessels from the surrounding tissue and blood vessels in live mouse models. This technique could well be extended to other anisotropic nanoparticle-based OCT contrast agents and presents significant progress toward enabling OCT molecular imaging.

Indexed as

NanoparticlesTomography, Optical CoherenceAnimalsDisease Models, AnimalGoldMiceGoldcontrast agentdepolarizationgold nanoparticlesin vivo imaginglymphatic systemoptical coherence tomography

Identifiers

PMID34644094
PMCPMC8555503
OpenAlexW3206682461

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.